Biopesticide for preventing and treating thrips of tea trees

By combining patchouli essential oil with tetrazolimide or epoxycaploprine, biopesticides are formed, and the problems of tea tree thrips resistance and pesticide residues are solved, and the goal of improving prevention and control effects and reducing environmental pressure is achieved.

CN118901736APending Publication Date: 2024-11-08SOUTH ASIAN TROPICAL AGRI SCI RES INST OF GUANGXI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410962876.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The long-term large-scale use and unreasonable application of chemical pesticides leads to the resistance of tea tree thrips and the problem of pesticide residues, which is difficult to effectively solve in the existing technology.

Method used

Combining patchouli essential oil with tetrazolimide or epoxycapridine to form a biological pesticide. The indoor biological activity test was conducted by the leaf tube membrane method, and the cotoxicity coefficient within the mass ratio was determined to be greater than 120, which showed an increase. Effective effect and improve prevention and control effect.

Benefits of technology

It reduces the risk of pest resistance, delays the generation and development of pest resistance, reduces the dosage of active ingredients, and reduces environmental pressure and pesticide residues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004950818470000031
    Figure BDA0004950818470000031
  • Figure BDA0004950818470000032
    Figure BDA0004950818470000032
Patent Text Reader

Abstract

The invention belongs to the technical field of biopesticides, and particularly relates to a biopesticide for preventing and treating thrips of tea trees. The invention relates to a biopesticide for preventing and treating tea tree thrips. The biopesticide for preventing and treating tea tree thrips is prepared from 1-45% of active ingredients and the balance of auxiliary ingredients, wherein the active component is formed by compounding plant essential oil and tetratolfenpyrad or epoxy thiacloprid; wherein the plant essential oil is pogostemon cablin essential oil. The plant essential oil pogostemon cablin essential oil is compounded with the tolfenpyrad or the epoxy thiacloprid, it is found that within a certain mass ratio range, the co-toxicity coefficient of the compounded formula on the tea tree thrips is larger than 120, the synergistic effect is achieved, compared with a single component, the prevention effect can be improved, the use amount of effective components can be reduced, and the environmental pressure and pesticide residues can be relieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biological pesticide control, and particularly relates to a biological pesticide for controlling tea tree thrips. Background Art

[0002] Tea trees belong to the genus Camellia of the Theaceae family. During their growth process, they are often harmed by a variety of diseases and pests. Tea thrips are an important regional explosive pest in my country's tea gardens. Their nymphs and adults suck the sap of young buds or old leaves of tea trees, causing strip-shaped scars to appear on the back of the leaves, making the leaves brown or lose their luster. In severe cases, the leaves harden, become brittle, scorched, and even fall off, affecting the quality and yield of tea.

[0003] At present, tea thrips are mainly controlled by chemical pesticides, such as spinetoram and chlorfenapyr. However, with the long-term and large-scale use of chemical agents and unreasonable application, such as the long-term single use of pesticides and excessive spraying concentrations, pest resistance and pesticide residue problems have arisen. In order to control resistance, different types and modes of action of pesticides can be compounded, and compound formulas with synergistic effects can be selected. While delaying the development of pest resistance, it can also improve the control effect of pests and expand the insecticide spectrum.

[0004] Patchouli essential oil is an oily substance extracted from the plant Patchouli of the genus Echinops of the Lamiaceae family. It has extremely high medicinal value and has inhibitory effects on common intestinal pathogens, dozens of skin pathogens and a variety of plant pathogens. The main components of patchouli essential oil are patchouli ketone, patchouli alcohol, patchoulene, isoguaiacene, epi-lignol alcohol and lignol ketone. In the prior art, it has been reported that patchouli essential oil and patchouli ketone have insecticidal activity, which shows that patchouli essential oil has the potential to be developed into a botanical biological pesticide.

[0005] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention and should not be regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art. Summary of the invention

[0006] The purpose of the present invention is to provide a biological pesticide for controlling tea thrips, so as to solve the problems caused by the long-term and large-scale use of chemical agents and unreasonable application.

[0007] To achieve the above object, the present invention provides the following technical solutions:

[0008] A biological pesticide for controlling tea thrips, which is prepared from 1-45% of active ingredients and the remainder of auxiliary ingredients; wherein the active ingredients are compounded from plant essential oil and tetrazopyrid or cyclohexanil; wherein the plant essential oil is patchouli essential oil.

[0009] Preferably, the mass ratio of the plant essential oil to tetrazobactam is 3-5:12-1.

[0010] Preferably, the mass ratio of the plant essential oil to cyclohexapride is 1-4:28-1.

[0011] Preferably, the formulation is a wettable powder or a dusting agent.

[0012] Compared with the prior art, the present invention has the following beneficial effects:

[0013] (1) The present invention compounds the plant essential oil patchouli essential oil with tetrazobactam or cyclohexanthracene, and finds that within a certain mass ratio range, the co-toxicity coefficient of the compound formula to tea tree thrips is greater than 120, showing a synergistic effect. Compared with a single component, the control effect can be improved, thereby reducing the amount of active ingredients used, reducing environmental pressure and pesticide residues.

[0014] (2) The patchouli essential oil of the present invention has a different insecticidal mechanism from tetrazopyrid or cyclohexanide, which can reduce the risk of drug resistance, delay the generation and development of pest resistance, and alleviate the problem of pest resistance. DETAILED DESCRIPTION

[0015] The following is a clear and complete description of the technical solution of the patent of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by technicians in this field without creative work are within the scope of protection of the present invention.

[0016] Example :Indoor biological activity test

[0017] 1. Test reagents

[0018] 98% Patchouli essential oil (Ji'an Huatianbao Chinese Herbal Medicine Biological Products Factory), 90% Tetrazodone TC (Bayer AG), 95% Cyclohexidine TC (Sichuan Hebang Biotechnology Co., Ltd.).

[0019] The test agent was first dissolved with dimethyl sulfoxide, and then diluted with 0.05% Triton X-100 aqueous solution to form a high-concentration single-dose stock solution; multiple groups of ratios were set up, and each single dose and each group of mixed ratios were diluted with 0.05% Triton X-100 aqueous solution to 7 gradient mass concentrations, with 50 mL of each mass concentration solution for standby use.

[0020] 2. Test pests

[0021] Tea thrips were collected from tea gardens and continuously raised for 5 generations with fresh and clean young buds and leaves of tea trees in an artificial climate chamber. The raising conditions were as follows: temperature (25±1)℃, light intensity L:D (16h:8h), relative humidity (65±5)%. The 2nd instar nymphs were selected as the test objects.

[0022] 3. Test methods

[0023] Use the leaf tube drug film method. Fill the centrifuge tube with the drug solution, leave it for 6 hours, pour out the drug solution, open the tube cover and let it dry. Punch multiple small holes in the centrifuge tube and the tube cover. The hole diameter should be based on the ability to prevent the test pests from escaping. Take fresh and clean young tea leaves of uniform thickness and make a leaf disc with a diameter of 1 cm. Immerse the leaf disc in the drug solution for 10 seconds, then take it out and let it dry. Then put the leaf disc together with the 1 cm 2 Place the dried filter paper pieces of different sizes into the centrifuge tubes treated with the corresponding concentration of the drug solution, with the back of the leaf disc facing upwards, one piece per tube. Inoculate the test pests in the centrifuge tubes, 25 heads / tube, cover the tubes and transfer them to the artificial climate box under the original conditions for continued breeding. Each tube is a replicate, and each concentration of the drug solution is set up for 4 replicates, and the treatment with 0.05% Triton X-100 aqueous solution is set as a blank control.

[0024] After 48 hours, the death of the test insects was investigated. The insects that could not crawl after being touched by the tip of a brush were considered dead. The total number of insects and the number of dead insects in each treatment were recorded respectively, and the corrected mortality rate of each treatment was calculated based on this. The DPS software was used to perform regression analysis on the logarithmic value of the concentration of each treatment and the corrected mortality probability value to calculate the LC of each treatment agent. 50 .

[0025]

[0026] In the above formula: P--mortality rate, unit is %; K--number of dead insects; N--total number of insects treated.

[0027]

[0028] In the above formula: P1--corrected mortality rate, unit is %; P t --Treatment mortality rate, in %; P0--blank control mortality rate, in %.

[0029] 4. Pharmaceutical evaluation

[0030] The Sun Yunpei method was used to calculate the co-toxicity coefficient (CTC value) of the mixture, and the type of joint action was evaluated based on the calculated co-toxicity coefficient value: a co-toxicity coefficient (CTC) ≥ 120 indicates a synergistic effect; a co-toxicity coefficient (CTC) ≤ 80 indicates an antagonistic effect; and a co-toxicity coefficient (CTC) 80 < 120 indicates an additive effect. The results are shown in Table 1-2.

[0031] Table 1 Indoor bioactivity test of patchouli essential oil and tetrazobactam against tea thrips

[0032] Drug name and ratio <![CDATA[LC 50 (mg / L)]]> ATI TTI CTC Patchouli essential oil 121.329 100.000 -- -- Tetracycline 6.635 1828.621 -- -- Patchouli essential oil 3: Tetrazodone 12 4.508 2691.415 1482.897 181.497 Patchouli essential oil 3: Tetrazodone 6 1.941 6250.850 1252.414 499.104 Patchouli essential oil 3: Tetrazodone 3 6.684 1815.215 964.310 188.240 Patchouli essential oil 3: Tetrazodone 1 10.992 1103.794 532.155 207.419 Patchouli essential oil 4: Tetrazodone 1 18.484 656.400 445.724 147.266 Patchouli essential oil 5: Tetrazodone 1 24.025 505.011 388.103 130.123

[0033] As shown in Table 1, the co-toxicity coefficients of patchouli essential oil and tetrazobactam in the mass ratio range of 3-5:12-1 are all greater than 120, that is, the biological activity of patchouli essential oil and tetrazobactam against tea thrips after compounding shows a synergistic effect.

[0034] Table 2 Indoor bioactivity test of patchouli essential oil and cyclohexanthropyrin against tea thrips

[0035] Drug name and ratio <![CDATA[LC 50 (mg / L)]]> ATI TTI CTC Patchouli essential oil 121.329 100.000 -- -- Cyclocloprid 11.586 1047.204 -- -- Patchouli Essential Oil 1: Cyclomethicone 28 6.960 1743.233 1014.541 171.825 Patchouli Essential Oil 1: Cyclomethicone 18 9.151 1325.855 997.351 132.938 Patchouli Essential Oil 1: Cyclomethicone 8 8.376 1448.532 941.959 153.779 Patchouli Essential Oil 1: Cyclomethicone 4 11.524 1052.838 857.763 122.742 Patchouli Essential Oil 1: Cyclomethicone 1 16.733 725.088 573.602 126.410 Patchouli essential oil 4: Cyclomethicone 1 29.826 406.789 289.441 140.543

[0036] As shown in Table 2, the co-toxicity coefficients of patchouli essential oil and cyclohexaprid in the mass ratio range of 1-4:28-1 are all greater than 120, that is, the biological activity of patchouli essential oil and cyclohexaprid against tea stick thrips shows a synergistic effect.

[0037] In summary, when patchouli essential oil is compounded with tetrazopyrid or cyclohexanil, it is found that within a certain mass ratio range, the co-toxicity coefficient of the compound formula to tea thrips is greater than 120, showing a synergistic effect. Compared with a single ingredient, the prevention effect can be improved, thereby reducing the dosage of the active ingredient, alleviating environmental pressure and pesticide residues.

[0038] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.

Claims

1. A biological pesticide for controlling tea thrips, characterized in that: The biological pesticide for controlling tea tree thrips is prepared from 1-45% of active ingredients and the remainder of auxiliary ingredients; wherein the active ingredients are compounded from plant essential oil and tetrazopyrid or cyclohexanil; wherein the plant essential oil is patchouli essential oil.

2. The biological pesticide for controlling tea thrips according to claim 1, characterized in that: The mass ratio of the plant essential oil to tetrazobactam is 3-5:12-1.

3. The biological pesticide for controlling tea thrips according to claim 1, characterized in that: The mass ratio of the plant essential oil to cyclohexanthelopride is 1-4:28-1.

4. The biological pesticide for controlling tea thrips according to claim 1, characterized in that: Its dosage form is wettable powder or dust.